Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Dolan

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute|February 19, 1997
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancerP G Johnston, R Mick, W Recant, et al.
Leukemia|August 4, 2007
Genome scan implicates adhesion biological pathways in secondary leukemiaC Hartford, W Yang, C Cheng, et al.
Clinical Pharmacology and Therapeutics|May 30, 2008
Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemiaJ Yang, A Bogni, C Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancerE E Vokes, M S Kies, D J Haraf, et al.
Cancer Research|March 31, 2001
Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 geneY J Hu, K V Korotkov, R Mehta, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferaseM Belanich, T Randall, M A Pastor, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferaseH S Friedman, A E Pegg, S P Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaH S Friedman, J Pluda, J A Quinn, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|February 19, 1997
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancerP G Johnston, R Mick, W Recant, et al.
Leukemia|August 4, 2007
Genome scan implicates adhesion biological pathways in secondary leukemiaC Hartford, W Yang, C Cheng, et al.
Clinical Pharmacology and Therapeutics|May 30, 2008
Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemiaJ Yang, A Bogni, C Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancerE E Vokes, M S Kies, D J Haraf, et al.
Cancer Research|March 31, 2001
Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 geneY J Hu, K V Korotkov, R Mehta, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferaseM Belanich, T Randall, M A Pastor, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferaseH S Friedman, A E Pegg, S P Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant gliomaH S Friedman, D M Kokkinakis, J Pluda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant gliomaH S Friedman, J Pluda, J A Quinn, et al.
Pageof 12